Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | growth hormone secretagogue receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | rhodopsin-like orphan GPCR | growth hormone secretagogue receptor | 289 aa | 243 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0132 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0132 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0132 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0132 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Partial agonist activity at human GHS-R1a expressed in HEK293T cells at 10'-5 M after 45 mins by HTRF-based IP3 turnover assay | ChEMBL. | 27072910 | |
IC50 (binding) | = 1.3 nM | BindingDB_Patents: Competitive Binding Assay. Competitive binding assay using ghrelin receptor. | ChEMBL. | No reference |
IC50 (binding) | = 1.3 nM | BindingDB_Patents: Competitive Binding Assay. Competitive binding assay using ghrelin receptor. | ChEMBL. | No reference |
IC50 (binding) | = 2 nM | Antagonist activity at human GHS-R1a transfected in CHO cells assessed as inhibition of ghrelin-induced intracellular calcium mobilization measured over 60 secs by fluo-4AM dye-based fluorometric method | ChEMBL. | 27072910 |
IC50 (binding) | = 4 nM | Antagonist activity at human GHS-R1a transfected in mouse LTK cells after 6 hrs by CRE/luciferase reporter gene assay in presence of ghrelin and rolipram | ChEMBL. | 27072910 |
Ki (binding) | = 10 nM | Displacement of [125I]-His9-ghrelin from human GHS-R1a transfected in pig LLC PK-1 cell membranes after 60 mins by gamma counting method | ChEMBL. | 27072910 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.